Quipt Home Medical Temettü

Temettü kriter kontrolleri 0/6

Quipt Home Medical does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

-0.4%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-0.4%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Earnings Release: Here's Why Analysts Cut Their Quipt Home Medical Corp. (TSE:QIPT) Price Target To CA$10.95

Aug 17

Is Quipt Home Medical (TSE:QIPT) A Risky Investment?

Aug 16

Quipt Home Medical Corp.'s (TSE:QIPT) 26% Price Boost Is Out Of Tune With Revenues

Jul 26

Returns At Quipt Home Medical (TSE:QIPT) Are On The Way Up

Jul 17

Investors Aren't Entirely Convinced By Quipt Home Medical Corp.'s (TSE:QIPT) Revenues

Apr 19

Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Feb 17

Earnings Update: Quipt Home Medical Corp. (CVE:QIPT) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Aug 18

Health Check: How Prudently Does Quipt Home Medical (CVE:QIPT) Use Debt?

Jul 13

When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?

Jun 08

Quipt Home Medical Corp. (CVE:QIPT) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 02

Does Protech Home Medical (CVE:PTQ) Have A Healthy Balance Sheet?

May 07

Protech Home Medical Corp. (CVE:PTQ) Could Be Less Than A Year Away From Profitability

Mar 29

Can You Imagine How Elated Protech Home Medical's (CVE:PTQ) Shareholders Feel About Its 331% Share Price Gain?

Feb 22

Calculating The Fair Value Of Protech Home Medical Corp. (CVE:PTQ)

Jan 18

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if QIPT's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if QIPT's dividend payments have been increasing.

Piyasaya Karşı Temettü Getirisi

Quipt Home Medical Piyasaya Karşı Temettü Getirisi

QIPT temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (QIPT)	n/a
Pazarın Alt %25'i (CA)	1.8%
Pazarın En İyi %25'i (CA)	6.1%
Sektör Ortalaması (Healthcare)	3.7%
Analist tahmini (QIPT) (3 yıla kadar)	n/a

Önemli Temettü: Unable to evaluate QIPT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate QIPT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate QIPT's payout ratio to determine if its dividend payments are covered by earnings.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as QIPT has not reported any payouts.

Quipt Home Medical Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Chairman recently bought CA$402k worth of stock

Price target decreased by 14% to CA$10.35

Earnings Release: Here's Why Analysts Cut Their Quipt Home Medical Corp. (TSE:QIPT) Price Target To CA$10.95

Is Quipt Home Medical (TSE:QIPT) A Risky Investment?

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Quipt Home Medical Corp. Provides Earnings Guidance for the Year 2024

New minor risk - Shareholder dilution

Quipt Home Medical Corp. to Report Q3, 2024 Results on Aug 14, 2024

Quipt Home Medical Corp.'s (TSE:QIPT) 26% Price Boost Is Out Of Tune With Revenues

Returns At Quipt Home Medical (TSE:QIPT) Are On The Way Up

Price target decreased by 11% to CA$12.00

Second quarter 2024 earnings released: US$0.032 loss per share (vs US$0.021 loss in 2Q 2023)

Quipt Home Medical Corp. to Report Q2, 2024 Results on May 15, 2024

Investors Aren't Entirely Convinced By Quipt Home Medical Corp.'s (TSE:QIPT) Revenues

Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Quipt Home Medical Corp., Annual General Meeting, Mar 27, 2024

Quipt Home Medical Corp. to Report Q1, 2024 Results on Feb 14, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Quipt Home Medical Corp. to Report Q4, 2023 Results on Dec 18, 2023

Now 21% undervalued after recent price drop

What Is Quipt Home Medical Corp.'s (TSE:QIPT) Share Price Doing?

Consensus EPS estimates fall by 97%

Calculating The Fair Value Of Quipt Home Medical Corp. (TSE:QIPT)

Consensus EPS estimates fall by 98%

Third quarter 2023 earnings: EPS misses analyst expectations

Quipt Home Medical Corp.(TSXV:QIPT) dropped from S&P/TSX Venture Composite Index

Now 21% undervalued after recent price drop

Consensus EPS estimates fall by 80%, revenue upgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 19%

Consensus EPS estimates fall by 20%

We Think Quipt Home Medical's (CVE:QIPT) Robust Earnings Are Conservative

Consensus EPS estimates increase by 37%

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Quipt Home Medical Corp., Annual General Meeting, Mar 24, 2023

Consensus revenue estimates increase by 21%

Investor sentiment improved over the past week

Consensus EPS estimates fall by 47%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Earnings Update: Quipt Home Medical Corp. (CVE:QIPT) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Consensus forecasts updated

Health Check: How Prudently Does Quipt Home Medical (CVE:QIPT) Use Debt?

Quipt Home Medical Corp. (TSXV : QIPT) acquired Hometown Medical, LLC.

Quipt Home Medical Corp. Reiterates Outlook for 2022

Quipt Home Medical Corp. (TSXV:QIPT) acquired Norcal Respiratory, Inc. for $3.1 million.

When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?

Second quarter 2022 earnings: EPS exceeds analyst expectations

Quipt Home Medical Corp. Reiterates Revenue Guidance for the First Quarter of Fiscal Year 2023

Quipt Home Medical Corp., Annual General Meeting, Jun 02, 2022

Quipt Home Medical Corp. Provides Earnings Guidance for the First Quarter of Fiscal Year 2023

Quipt Home Medical Corp. Appoints Brian J. Wessel as an Independent Director and Chair of the Audit Committee

Forecast breakeven date pushed back to 2023

Full year 2021 earnings: EPS misses analyst expectations

Quipt Home Medical Corp Receives Letter from Nasdaq Notifying Nom-Compliance

Quipt Home Medical Corp. Reiterates Earnings Guidance for the Fiscal Year 2022

Quipt Home Medical Corp. (TSXV:QIPT) completed the acquisition of At Home Health Equipment, Inc. for approximately $13.1 million.

Quipt Home Medical Corp. Provides Earnings Guidance for the Fiscal Year 2022

Third quarter 2021 earnings released: EPS US$0.20 (vs US$0.12 loss in 3Q 2020)

Quipt Home Medical Corp. (TSXV:QIPT) acquired Medical West Healthcare Center, LLC for $2.4 million.

Forecast breakeven moved forward to 2021

Quipt Home Medical Corp. (CVE:QIPT) Shares Could Be 43% Below Their Intrinsic Value Estimate

Does Protech Home Medical (CVE:PTQ) Have A Healthy Balance Sheet?

Protech Home Medical Corp. (CVE:PTQ) Could Be Less Than A Year Away From Profitability

First quarter 2021 earnings released: EPS US$0.002 (vs US$0.016 loss in 1Q 2020)

Can You Imagine How Elated Protech Home Medical's (CVE:PTQ) Shareholders Feel About Its 331% Share Price Gain?

Protech Home Medical Corp., Annual General Meeting, Apr 19, 2021

Protech Home Medical Corp. (TSXV:PTQ) completed the acquisition of Mayhugh's Medical Equipment for $5.8 million.

Price target raised to CA$2.95

Full year 2020 earnings released: CA$0.062 loss per share (vs CA$0.11 loss in FY 2019)

Earnings beat expectations, revenue disappoints

New 90-day high: CA$2.18

Protech Home Medical Corp. to Report Q4, 2020 Results on Jan 29, 2021

Calculating The Fair Value Of Protech Home Medical Corp. (CVE:PTQ)

New 90-day high: CA$1.73